Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Pediatric Surgery International
|
March 4, 2024
Comorbidities are not associated with pain symptom or recurrence in patients with pilonidal disease
Akanksha Sabapaty, Fereshteh Salimi-Jazi, Claire Abrajano, et al.
Journal of Pediatric Surgery
|
March 18, 2023
Increasing Amount of Hair Reduction using Laser Correlates with Lower Probability of Recurrence in Patients with Pilonidal Disease
Fereshteh Salimi-Jazi, Claire Abrajano, Razie Yousefi, et al.
Multiple Sclerosis and Related Disorders
|
May 28, 2023
Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND study
Le H Hua, Amit Bar-Or, Stanley L Cohan, et al.
Journal of Pediatric Surgery
|
July 22, 2022
Adoption of a standardized treatment protocol for pilonidal disease leads to low recurrence
Talha Rafeeqi, Claire Abrajano, Fereshteh Salimi-Jazi, et al.
The Journal of Headache and Pain
|
November 20, 2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study
Shengyuan Yu, Byung-Kun Kim, Hebo Wang, et al.
Pediatric Surgery International
|
July 17, 2022
Burden of pilonidal disease and improvement in quality of life after treatment in adolescents
Fereshteh Salimi-Jazi, Claire Abrajano, Deanna Garza, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 17, 2021
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study
Jun-Ichi Kira, Jin Nakahara, Denis V Sazonov, et al.
The Journal of Headache and Pain
|
September 19, 2023
Serum tau protein elevation in migraine: a cross-sectional case-control study
Lucas Hendrik Overeem, Bianca Raffaelli, Robert Fleischmann, et al.
Headache
|
May 24, 2024
Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
Shuu-Jiun Wang, Byung-Kun Kim, Hebo Wang, et al.
Frontiers in Immunology
|
April 18, 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials
Tjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Pediatric Surgery International
|
March 4, 2024
Comorbidities are not associated with pain symptom or recurrence in patients with pilonidal disease
Akanksha Sabapaty, Fereshteh Salimi-Jazi, Claire Abrajano, et al.
Journal of Pediatric Surgery
|
March 18, 2023
Increasing Amount of Hair Reduction using Laser Correlates with Lower Probability of Recurrence in Patients with Pilonidal Disease
Fereshteh Salimi-Jazi, Claire Abrajano, Razie Yousefi, et al.
Multiple Sclerosis and Related Disorders
|
May 28, 2023
Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND study
Le H Hua, Amit Bar-Or, Stanley L Cohan, et al.
Journal of Pediatric Surgery
|
July 22, 2022
Adoption of a standardized treatment protocol for pilonidal disease leads to low recurrence
Talha Rafeeqi, Claire Abrajano, Fereshteh Salimi-Jazi, et al.
The Journal of Headache and Pain
|
November 20, 2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study
Shengyuan Yu, Byung-Kun Kim, Hebo Wang, et al.
Pediatric Surgery International
|
July 17, 2022
Burden of pilonidal disease and improvement in quality of life after treatment in adolescents
Fereshteh Salimi-Jazi, Claire Abrajano, Deanna Garza, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 17, 2021
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study
Jun-Ichi Kira, Jin Nakahara, Denis V Sazonov, et al.
The Journal of Headache and Pain
|
September 19, 2023
Serum tau protein elevation in migraine: a cross-sectional case-control study
Lucas Hendrik Overeem, Bianca Raffaelli, Robert Fleischmann, et al.
Headache
|
May 24, 2024
Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
Shuu-Jiun Wang, Byung-Kun Kim, Hebo Wang, et al.
Frontiers in Immunology
|
April 18, 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials
Tjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, et al.
Page
of 5